CRYL1 and benign prostatic hyperplasia: In contrast, 100-fold excess of unlabeled Cry proteins did not reduce the weak binding of biotinylated Cry proteins to BBMV from BPH and PWS, supporting that the three Cry proteins tested had no specific binding to these BBMV.